|
Published by: Kalorama Information
Published: Aug. 1, 2001 - 111 Pages Order 2 or more reports in this series and save 25-40%! Call 800-298-5699
Table of Contents
1. Executive Summary
- Market Drivers
- Market Size and Growth
- Competitor and Market Analysis
2. Introduction and Overview
- Scope of the Report
- Methodology
- History of Oral Drug Delivery
- Phases of Drug Action
- Barriers to Oral Drug Delivery
- Controlled-Release/Sustained-Release
- Delayed Release and Modified Release
- Fast Dissolving
- Pulsatile Release
- Taste-Masked
- Microemulsion and Others
3. Key Trends and Demographics
- The Elderly
- Regulatory Environment
- Patent Protection and Extension
- Earlier Involvement
- Consolidation
- Proprietary Product Development
- Implications for Generic and Over-the-Counter Products
4. New Developments
- Macromolecule Delivery
- Delivery of Hydrophobic Drugs
- Other Delivery Solutions
5. Market Size and Growth
- The Total Oral Drug Delivery Market
- Oral Delivery Technology Only Market
6. Competitive and Market Analysis
7. Company Profiles
- ALZA Corporation
- Andrx Pharmaceuticals
- Biovail Corporation
- Elan Corporation, plc
- Emisphere Technologies, Inc.
- KV Pharmaceutical
- Labopharm, Inc.
- Penwest Pharmaceutical Company
- SkyePharma PLC
8. Companies in Brief
- Alkermes, Inc.
- BioProgress Technologies International, Inc.
- CIMA Labs, Inc.
- DepoMed, Inc.
- Endorex, Inc.
- Eurand, Inc.
- Kos Pharmaceuticals, Inc.
- Lipocine, Inc.
- Yamanouchi Pharma Technologies, Inc.
Appendix: Company Directory
List of Exhibits
Table 2-1: Selected Types of Oral Solid Preparations
Table 2-2: Sequence of Drug Action
Table 3-1: Worldwide Population by Age Group, 1995-2005
Table 3-2: Recent Consolidations in the Drug Delivery Market
Table 5-1: The Worldwide Market for Oral Drug Delivery Systems by Type,
1995-2005
Table 5-2: The Worldwide Market for Oral Drug Delivery Systems Market
Share by Type, 1995-2005
Table 5-3: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 1995-2005
Table 5-4: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
Table 6-1: Worldwide Market for Oral Drug Delivery System, Revenues and Market Share by Supplier, 2000
Table 6-2: Selected Product Mix by Company
Figure 3-1: Worldwide Population by Age Group, 1995-2005
Figure 5-1: The Worldwide Market for Oral Drug Delivery Systems
Revenues by Type, 1995-2005
Figure 5-2: The Worldwide Market for Oral Drug Delivery Systems
Share by Type, 2000
Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems
Share by Type, 2005
Figure 5-4: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
Figure 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2000
Figure 5-6: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2005
Figure 6-1: Worldwide Market for Oral Drug Delivery Systems Market Share by Leading Supplier, 2000
AbstractDrug Delivery Series: The Market for Oral Drug Delivery Systems: Volume 1
The accelerated pace of oral drug delivery system development has been fostered by the need to deliver medications to patients more efficiently and with fewer side effects. This report is the first in a series of five volumes that analyzes the market for drug delivery systems. Volume one presents a complete overview of current and future market directions, up-to-date development information, and detailed market analysis for oral drug delivery systems. It will help participants and potential participants in the market to understand the financial advantages of investing in drug delivery technologies. Market shares are assessed and the 10 top companies are profiled.
Get Full Details About This Report >>
|
